Osaic Holdings’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-50
| Closed | -$153 | – | 8253 |
|
|
2025
Q3 | $153 | Hold |
50
| – | – | ﹤0.01% | 7719 |
|
|
2025
Q2 | $168 | Hold |
50
| – | – | ﹤0.01% | 7524 |
|
|
2025
Q1 | $145 | Hold |
50
| – | – | ﹤0.01% | 7203 |
|
|
2024
Q4 | $134 | Hold |
50
| – | – | ﹤0.01% | 7214 |
|
|
2024
Q3 | $185 | Buy |
+50
| New | +$254 | ﹤0.01% | 7189 |
|
|
2024
Q2 | – | Sell |
-50
| Closed | -$428 | – | 7653 |
|
|
2024
Q1 | $428 | Hold |
50
| – | – | ﹤0.01% | 6849 |
|
|
2023
Q4 | $372 | Hold |
50
| – | – | ﹤0.01% | 6936 |
|
|
2023
Q3 | $500 | Sell |
50
-9
| -15% | -$100 | ﹤0.01% | 6987 |
|
|
2023
Q2 | $609 | Hold |
59
| – | – | ﹤0.01% | 7002 |
|
|
2023
Q1 | $611 | Hold |
59
| – | – | ﹤0.01% | 7086 |
|
|
2022
Q4 | $1K | Hold |
59
| – | – | ﹤0.01% | 6994 |
|
|
2022
Q3 | $1K | Hold |
59
| – | – | ﹤0.01% | 7101 |
|
|
2022
Q2 | $1K | Hold |
59
| – | – | ﹤0.01% | 7180 |
|
|
2022
Q1 | $168K | Buy |
59
+9
| +18% | +$324 | ﹤0.01% | 4181 |
|
|
2021
Q4 | $2K | Hold |
50
| – | – | ﹤0.01% | 7069 |
|
|
2021
Q3 | $4K | Hold |
50
| – | – | ﹤0.01% | 6665 |
|
|
2021
Q2 | $4K | Hold |
50
| – | – | ﹤0.01% | 6524 |
|
|
2021
Q1 | $6K | Buy |
+50
| New | +$5.54K | ﹤0.01% | 6099 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 6610 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6446 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6373 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6211 |
|
Osaic Holdings's CSCI Position: Q4 2025 in Review
Osaic Holdings sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q4 2025, closing a stake of 50 shares — an estimated $153 sold.
Osaic Holdings first reported a position in CSCI in Q1 2021 and held it in 18 quarters. The position peaked at $168K in Q1 2022. 0 funds tracked by Wall St. Rank hold CSCI as of Q4 2025.
- Osaic Holdings reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q4 2025 after selling out during the quarter.
- Osaic Holdings sold 50 COSCIENS Biopharma Inc. Common Stock shares in Q4 2025, an estimated $153.
- Osaic Holdings first reported a position in COSCIENS Biopharma Inc. Common Stock in Q1 2021 and held it in 18 quarters.
- Osaic Holdings's COSCIENS Biopharma Inc. Common Stock position peaked at $168K in Q1 2022.
- 0 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q4 2025.
Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.